Induction of Tissue Injury and Altered Cardiovascular Performance by Platelet-Activating Factor: Relevance to Multiple Systems Organ Failure

Adnot, 1986, Interference of BN 52021, a PAF-acether antagonist, with endotoxin-induced hypotension in the guinea pig, Pharmacol Res Commun, 18, 100, 10.1016/0031-6989(86)90052-4 Alam, 1983, Metabolism of platelet-activating factor by blood platelets and plasma, Lipids, 18, 534, 10.1007/BF02535393 Albert, 1983, Biosynthesis of l-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet-activating factor) from l-alkyl-2-acetyl-sn-acyl-sn-glycero-3-phosphocholine by rat alveolar macrophages, J Biol Chem, 258, 97, 10.1016/S0021-9258(18)33225-3 Alloatti, 1986, Effect of platelet-activating factor (PAF) on human cardiac muscle, Int Arch Allegy Appl Immunol, 79, 108, 10.1159/000233953 Alloatti, 1987, Protective effect of verapamil on the cardiac and circulatory alterations induced by platelet-activating factor, J Cardiovasc Pharmacol, 9, 181, 10.1097/00005344-198702000-00009 Armstead, 1988, Platelet activating factor: A potent constrictor of cerebral arterioles in newborn pigs, Circ Res, 62, 1, 10.1161/01.RES.62.1.1 Barbaro, 1966, Antigen-induced histamine release from platelets of rabbits producing homologous PCA antibody, Proc Soc Exptl Biol Med, 122, 1245, 10.3181/00379727-122-31371 Baranes, 1986, The effects of PAF-acether on the cardiovascular system and their inhibition by a new highly specific PAF-acether receptor antagonist, BN 52021, Pharmacol Res Commun, 18, 717, 10.1016/0031-6989(86)90114-1 Beijer, 1987, The involvement of platelet-activating factor in endotoxin-induced pulmonary platelet recruitment in the guinea pig, Br J Pharmacol, 92, 803, 10.1111/j.1476-5381.1987.tb11384.x Benveniste, 1974, Characteristics and semipurification of platelet-activating factor from human and rabbit leukocytes, Fed Proc, 33, 797 Benveniste, 1974, Platelet-activating factor, a new mediator of anaphylaxis and immune complex deposition from rabbit and human basophils, Nature, 249, 581, 10.1038/249581a0 Benveniste, 1983, The actions of PAF-acether (platelet-activating factor) on guinea-pig isolated heart preparations, Br J Pharmacol, 80, 81, 10.1111/j.1476-5381.1983.tb11052.x Benveniste, 1985, A role for PAF-acether (platelet-activating factor) in platelet-dependent vascular diseases?, Circulation, 72, 713, 10.1161/01.CIR.72.4.713 Benveniste, 1982, Biosynthesis of platelet-activating factor (PAF-acether), II. Involvement of phospholipase A2 in the formation of PAF-acether and lyso-PAF-acether from rabbit platelets. Thromb Res, 25, 375 Benveniste, 1972, Leukocyte-dependent histamine release from rabbit platelets: The role of IgE, basophils, and a platelet-activating factor, J Exp Med, 136, 1356, 10.1084/jem.136.6.1356 Benveniste, 1977, Structural analysis of purified platelet activating factor by lipases, Nature, 269, 170, 10.1038/269170a0 Berti, 1986, Cardiovascular and pulmonary activity of platelet-activating factor (PAF-acether) and its derivatives, Pharmacol Res Commun, 18, 557, 10.1016/0031-6989(86)90150-5 Bessin, 1983, Acute circulatory collapse caused by PAF in dogs, Eur J Pharmacol, 86, 403, 10.1016/0014-2999(83)90190-5 Blackwell, 1983, Inhibition of phospholipase, Brit Med Bull, 39, 260, 10.1093/oxfordjournals.bmb.a071830 Blank, 1983, Inactivation of l-alkyl-2-acetyl-sn-glycero-3-phos-phocholine by a plasma acetylhydrolase: higher activities in hypertensive rats, Biochem Biophys Res Commun, 113, 666, 10.1016/0006-291X(83)91778-3 Blank, 1984, Conversion of l-alkyl-2-acetyl-sn-glycerols to platelet activating factor and related phospholipids by rabbit platelets, Biochem Biophys Res Commun, 124, 156, 10.1016/0006-291X(84)90930-6 Blank, 1981, A specific acetylhydrolase for l-alkyl-2-acetyl-sn-glycero-3-phosphocholine (a hypotensive and platelet-activating lipid), J Biol Chem, 256, 175, 10.1016/S0021-9258(19)70115-X Bradley, 1987, Circulatory effects of platelet-activating factor in the newborn, Circulation, 76, IV Braquet, 1987, The ginkoglides: potent platelet-activating factor antagonists isolated from Ginkgo biloba I.: Chemistry, pharmacology, and clinical applications, Drugs of the Future, 12, 643, 10.1358/dof.1987.012.07.77903 Braquet, 1985, BN 52021 and related compounds: A new series of highly specific PAF-acether receptor antagonists isolated from Ginkgo biloba, Blood Vessels, 16, 559 Braquet, 1987, Perspectives in platelet-activating factor research, Pharmacol Rev, 39, 97 Braquet, 1986, Pharmacology of platelet-activating factor, Transplant Proc, 5, 10 Burhop, 1986, Platelet-activating factor increases lung vascular permeability to protein, J Appl Physiol, 61, 2210, 10.1152/jappl.1986.61.6.2210 Bussolino, 1980, Effect of prostacyclin on platelet-activating factor induced rabbit platelet aggregation, Prostaglandins, 20, 781, 10.1016/0090-6980(80)90133-1 Cabot, 1982, Metabolism of l-alkyl-2-acetyl-sn-glycero-3-phos-phocholine by cell cultures, Life Sci, 31, 2891, 10.1016/0024-3205(82)90680-4 Caillard, 1982, Hypotensive activity of PAF-acether in rats, Agents and Actions, 12, 725, 10.1007/BF01965093 Camussi, 1983, The release of platelet-activating factor from human endothelial cells in culture, J Immunology, 131, 2397, 10.4049/jimmunol.131.5.2397 Camussi, 1987, Tumor necrosis factor/cachectin stimulates peritoneal macrophages, polymorphonuclear neutrophils, and vascular endothelial cells to synthesize and release platelet-activating factor, J Exp Med, 166, 1390, 10.1084/jem.166.5.1390 Casals-Stenzel, 1987, Bronchial and vascualr effects of PAF in the rat isolated lung are completely blocked by WEB 2086, a novel specific PAF antagonist, Br J Pharmacol, 91, 799, 10.1111/j.1476-5381.1987.tb11278.x Casals-Stenzel, 1987, Pharmacological actions of WEB 2086, a new specific antagonist of platelet activating factor, J Pharmacol Exptl Therap, 241, 974 Cervoni, 1983, Aortic vascular and atrial responses to (±)-l-0-octadecyl-2-acetyl-glyceryl-3-phosphorylcholine, Br J Pharmacol, 79, 667, 10.1111/j.1476-5381.1983.tb10003.x Chilton, 1983, Selective acylation of lyso platelet activating factor by arachidonate in human neutrophils, J Biol Chem, 258, 7268, 10.1016/S0021-9258(18)32170-7 Chung, 1986, Airway hyperresponsiveness induced by platelet-activating factor: Role of thromboxane generation, J Pharmacol Exptl Therap, 236, 580 Coeffier, 1983, Inhibition of rabbit platelet aggregation by the Ca2+-antagonists verapamil and diltiazem and by trifluoperazine, Thromb Res, 31, 565, 10.1016/0049-3848(83)90454-1 Darius, 1986, Role of platelet-activating factor-acether in mediating guinea pig anaphylaxis, Science, 232, 58, 10.1126/science.3082008 Demopoulos, 1979, Platelet-activating factor, Evidence for 1-0-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators). J Biol Chem, 254, 9355 Dillon, 1988, Effect of platelet-activating factor on microvascular permselectivity: Dose-dependent relations and pathways of action in the hamster cheek pouch microcirculation, Circ Res, 62, 732, 10.1161/01.RES.62.4.732 Di Marzo, 1987, Platelet activating factor-mediated leukotriene biosynthesis in rat lungs: Effect of prostaglandins E1 and F1α, Biochem Biophys Res Commun, 147, 1213, 10.1016/S0006-291X(87)80199-7 Doebber, 1984, Platelet-activating factor intravenous infusion in rats stimulates vascular lysosomal hydrolase secretion independent of blood neutrophils, Biochem Biophysiol Res Commun, 125, 980, 10.1016/0006-291X(84)91380-9 Engler, 1987, Consequences of activation and adenosine-mediated inhibition of granulocytes during myocardial ischemia, Fed Proc, 46, 2407 Farr, 1980, Preliminary studies of an acid-labile factor (ALF) in human sera that inactivates platelet-activating factor (PAF), Clin Immunol Immunopathol, 15, 318, 10.1016/0090-1229(80)90044-6 Farr, 1983, Human serum acid-labile factor is an acyl-hydrolase that inactivates platelet-activating factor, Fed Proc, 42, 3120 Feuerstein, 1984, Effect of platelet-activating factor on coronary circulation of the domestic pig, Am J Physiol, 246, H466 Feidler, 1987, Comparison of cardiac and hemodynamic effects of platelet-activating factor-acether and leukotriene D4 in anesthetized dogs, Basic Res Cardiol, 82, 197, 10.1007/BF01907067 Gillespie, 1985, Impact of platelet activating factor on vascular responsiveness in isolated rat lungs, J Pharmacol Exptl Therap, 236, 396 Goldstein, 1984, Effect of platelet-activating factor (PAF) on blood flow distribution in the spontaneously hypertensive rat, Life Sci, 35, 1373, 10.1016/0024-3205(84)90394-1 Goldstein, 1986, Coronary and pulmonary vascular effects of leukotrienes and PAF-acether, Pharmacol Res Commun, 18, 151, 10.1016/0031-6989(86)90048-2 Gomez-Cambronero, 1984, The role of calcium ions in the process of acetyltransferase activation duing the formation of platelet-activating factor (PAF-acether), Biochem J, 219, 419, 10.1042/bj2190419 Gomez-Cambronero, 1985, Modulation of lyso-platelet-activating factor: acetyl-CoA acetyltransferase from rat splenic microsomes, The role of calcium ions. Biochim Biophys Acta, 845, 511, 10.1016/0167-4889(85)90218-6 Hanahan, 1986, Platelet activating factor: A biologically active phosphoglyceride, Annu Rev Biochem, 55, 483, 10.1146/annurev.bi.55.070186.002411 Handley, 1986, Evidence for distinct systemic extravasation effects of platelet activating factor, leukotrienes B4, C4, D4, and histamine in the guinea pig, Prostag Leuko Med, 21, 269, 10.1016/0262-1746(86)90048-X Handley, 1985, Evidence for a direct effect on vascular permeability of platelet-activating factor-induced hemoconcentration in the guinea pig, Thromb Haemostas, 54, 756, 10.1055/s-0038-1660126 Handley, 1986, Platelet activating factor and inflammation in atherogenesis: Targets for drug development, Drug Dev Res, 7, 361, 10.1002/ddr.430070407 Handley, 1984, Evaluation of dose and route effects of platelet activating factor-induced extravasation in the guinea pig, Thromb Haemostas, 52, 34, 10.1055/s-0038-1661131 Handley, 1987, Biological properties of the antagonist SRI 63-441 in the PAF and endotoxin models for hypotension in the rat and dog, Immunopharmacology, 13, 125, 10.1016/0162-3109(87)90049-X Handley, 1987, In vitro and in vivo pharmacological profiles of the PAF receptor antagonist SRI 63-675, Thromb Haemostas, 57, 187, 10.1055/s-0038-1651091 Heffner, 1983, Acetyl glyceryl ether phosphorylcholine-stimulated human platelets cause pulmonary hypertension and edema in isolated rabbit lungs, J Clin Invest, 71, 351, 10.1172/JCI110776 Henson, 1969, Role of complement and leukocytes in immunologic release of vaosactive amines from platelets, Fed Proc, 28, 1721 Henson, 1979, Release of vasoactive amines from rabbit platelets induced by sensitized mononuclear leukocytes and antigen, J Exp Med, 131, 287, 10.1084/jem.131.2.287 Hock, 1984, Inhibitors of lipoxygenase products improve survival in traumatic shock, Prostaglandins, 28, 557, 10.1016/0090-6980(84)90244-2 Houston, 1984, Platelet activating factor induces endothelium-independent relaxation of isolated canine blood vessels, Physiologist, 27, 282 Hsueh, 1987, Platelet-activating factor: An endogenous mediator for bowel necrosis in endotoxemia, FASEB J, 1, 403, 10.1096/fasebj.1.5.3678700 Inarrea, 1985, Synthesis of PAF-acether and blood volume changes in gram-negative sepsis, Immunopharmacology, 9, 45, 10.1016/0162-3109(85)90046-3 Jackson, 1986, Platelet-activating factor and the release of a platelet-derived coronary artery vasodilator substance in the canine, Circ Res, 58, 218, 10.1161/01.RES.58.2.218 Jancar, 1988, Immune-complex-induced pancreatitis, Effect of BN 52021, a selective antagonist of platelet activating factor. Prostaglandins, 35, 757 Kasuya, 1984, Possible role of endothelium in the vasodilator response of rat thoracic aorta to platelet activating factor (PAF), Pharmacol Dyn, 7, 138, 10.1248/bpb1978.7.138 Kenzora, 1984, Effects of acetyl glyceryl ether of phosphorylcholine (platelet activating factor) on ventricular preload, afterload, and contractility in dogs, J Clin Invest, 74, 1193, 10.1172/JCI111528 Kochanek, 1987, Platelet activating factor receptor blockade enhances recovery after multifocal brain ischemia, Life Sci, 41, 2639, 10.1016/0024-3205(87)90278-5 Koltai, 1986, Effect of BN 52021, a specific PAF-acether antagonist, on cardiac anaphylaxis in Langendorff hearts isolated from passively sensitized guinea pigs, Eur J Pharmacol, 130, 133, 10.1016/0014-2999(86)90192-5 Kornecki, 1984, Platelet-activating factor induced aggregation of human platelets specifically inhibited by triazolobenzo-diazepines, Science, 226, 1954, 10.1126/science.6150550 Lagente, 1988, Involvement of PAF-acether in anaphylactic bronchoconstriction induced in guinea pigs by aerosolized antigen, Int Arch Allergy Immunol, 85, 14, 10.1159/000234469 Lang, 1987, Attenuation of endotoxin-induced increase in glucose metabolism by platelet-activating factor antagonist, Circ Shock, 23, 179 Ledwig, 1984, Modulation of platelet-activating factor (PAF) synthesis and release from human polymorphonuclear leukocytes (PMN): Role of extracellular Ca2+, Arch Biochem Biophysiol, 232, 102, 10.1016/0003-9861(84)90525-3 Lee, 1986, A new de novo for the formation of l-alkyl-2-acetyl-sn-glycerols, precursors of platelet activating factor, J Biol Chem, 261, 5373, 10.1016/S0021-9258(19)57225-8 Lefer, 1987, Interaction between myocardial depressant factor and vasoactive mediators with ischemia and shock, Am J Physiol, 252, R193 Lefer, 1979, Protective effects of a novel thromboxane analog in lethal traumatic shock, Prostag Med, 3, 139, 10.1016/0161-4630(79)90097-1 Lefer, 1984, Pathophysiological mechanisms of sudden death induced by platelet activating factor, Br J Pharmacol, 83, 125, 10.1111/j.1476-5381.1984.tb10126.x Lefer, 1986, Failure of endothelium to mediate potential vasoactive action of platelet activating factor (PAF), IRCS Med Sci, 14, 356 Lenihan, 1983, Regulation of platelet activating factor synthesis: Modulation of 1-alkyl-2-lyso-sn-3-phosphocholine: acetyl-CoA acetyl-transferase by phosphorylation and dephosphorylation in rat spleen microsomes, Biochem Biophysiol Res Commun, 120, 834, 10.1016/S0006-291X(84)80182-5 Lepran, 1985, Ischemia aggravating effects of platelet-activating factor in acute myocardial ischemia, Basic Res Cardiol, 80, 135, 10.1007/BF01910460 Levi, 1984, Acetyl glyceryl ether phosphorylcholine (AGEPC): A putative mediator of cardiac anaphylaxis in the guinea pig, Circ Res, 54, 117, 10.1161/01.RES.54.2.117 Levy, 1983, Calmodulin antagonist inhibits aggregation of human, guinea pig, and rabbit platelets induced with platelet activating factor, FEBS Lett, 154, 262, 10.1016/0014-5793(83)80161-6 Lucchesi, 1987, Interaction of the formed elements of blood with the coronary vasculature in vivo, Fed Proc, 46, 63 Mclntyre, 1984, Phospholipid-induced human platelet activation: effects of calcium channel blockers and calcium chelators, Thromb Res, 31, 823 McKean, 1985, Phospholipid biosynthesis in human platelets, The acylation of lyso-platelet-activating factor. Biochem J, 225, 723 McMurtry, 1986, Platelet-activating factor causes pulmonary vasodilation in the rat, Am Rev Respir Dis, 134, 757 Meuller, 1984, 1-0-alkyl-linked glycero-phospholipids of human neutrophils: Distribution of arachidonate and other acyl residues in the ether-linked and diacyl species, J Lipid Res, 25, 383, 10.1016/S0022-2275(20)37812-3 Miyamoto, 1985, ONO-6240: A new potent antagonist of platelet-activating factor, Adv Prostag Thromb Leuko Res, 15, 719 Namm, 1982, Species specificity of the platelet responses to 1-0-alkyl-2-acetyl-sn-glycero-phosphocholine, Thromb Res, 25, 341, 10.1016/0049-3848(82)90234-1 Ninio, 1982, Biosynthesis of platelet-activating factor. I. Evidence for an acetyltransferase activity in murine macrophages, Biochim Biophys Acta, 710, 23, 10.1016/0005-2760(82)90185-0 Okamoto, 1986, Platelet activating factor (PAF) involvement in endotoxin-induced thrombocytopenia in rabbits: Studies with FR-900452, a specific inhibitor of PAF, Thromb Res, 42, 661, 10.1016/0049-3848(86)90344-0 Olanoff, 1985, Protective effects of trans-13-APT, a thromboxane receptor antagonist, in endotoxemia, J Cardiovasc Pharmacol, 7, 114, 10.1097/00005344-198501000-00019 Otsuka, 1985, Hypotensive mechanism of acetyl glyceryl ether phosphorylcholine (AGEPC) in dogs, Effects on hemodynamics and humoral factors. Prostag Leuko Med, 19, 25, 10.1016/0262-1746(85)90158-1 Palmer, 1987, Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor, Nature, 327, 524, 10.1038/327524a0 Pieter, 1987, Platelet-activating factor induced leukotriene C4 synthesis by purified human eosinophils, Prostaglandins, 34, 205, 10.1016/0090-6980(87)90244-9 Pinckard, 1979, Physicochemical and functional identity of rabbit platelet activating factor (PAF) released in vivo during IgE anaphylaxis with PAF released in vitro from IgE sensitized basophils, J Immunol, 123, 1847, 10.4049/jimmunol.123.4.1847 Piper, 1986, Coronary vasoconstriction in the rat, isolated perfused heart induced by platelet-activating factor is mediated by leukotriene C4, Br J Pharmacol, 88, 595, 10.1111/j.1476-5381.1986.tb10240.x Piper, 1987, Antagonism of vasoconstriction induced by platelet-activating factor in guinea pig perfused hearts by selective platelet-activating factor receptor antagonists, Br J Pharmacol, 90, 687, 10.1111/j.1476-5381.1987.tb11231.x Pirotzky, 1985, Vascular permeability induced by PAF-acether (platelet-activating factor) in the isolated perfused rat kidney, Agents and Actions, 16, 7, 10.1007/BF01999630 Pirotzky, 1984, PAF-acether-induced plasma exudation in rat skin is independent of platelets and neutrophils, Microcirc Endo Lymph, 1, 107 Prescott, 1984, Human endothelial cells in culture produce platelet-activating factor (l-alkyl-2-acetyl-sn-glycero-3-phosphocholine) when stimulated with thrombin, Proc Natl Acad Sci USA, 81, 3534, 10.1073/pnas.81.11.3534 Rennoij, 1981, Biosynthesis of l-alkyl-2-acetyl-sn-glycerol-3-phosphocholine (platelet-activating factor and a hypotensive lipid) by cholinephosphotransferase in various rat tissues, Biochim Biophysiol Acta, 663, 545, 10.1016/0005-2760(81)90182-X Riedel, 1987, The effect of PAF (platelet-activating factor) on experimental cardiac arrhythmias and its inhibition by substances influencing arachidonic acid metabolites, Prostag Leuko Med, 28, 103, 10.1016/0262-1746(87)90051-5 Robertson, 1987, Negative inotropic effect of platelet-activating factor on human myocardium: A pharmacological study, J Pharmacol Exptl Therap, 243, 834 Robinson, 1985, Metabolism of platelet-activating factor by rat alveolar macrophages: lyso-PAF as an obligatory intermediate in the formation of alkylarachidonoyl glycerophosphocholine species, Biochem Biophys Acta, 837, 52, 10.1016/0005-2760(85)90084-0 Saeki, 1985, Effects of l-alkyl-2-acetyl-sn-glycerol-3-phosphocho-line (platelet-activating factor) on cardiac function in perfused guinea-pig heart, Life Sci, 37, 325, 10.1016/0024-3205(85)90502-8 Saunders, 1987, Platelet-activating factor antagonists, Ann Rev Pharmacol Toxicol, 27, 237, 10.1146/annurev.pa.27.040187.001321 Scherf, 1986, Hemodynamic effects of platelet activating factor in the dog kidney in vivo, Hypertension, 8, 737, 10.1161/01.HYP.8.9.737 Schwertschlag, 1987, L-platelet activating factor induces changes in renal vascular resistance, vascular reactivity, and renin release in the isolated perfused rat kidney, Circ Res, 60, 534, 10.1161/01.RES.60.4.534 Shen, 1985, Characterization of a platelet-activating factor receptor antagonist isolated from haifenteng (Piper futokadsurae): Specific inhibition of in vitro and in vivo platelet-activating factor-induced effects, Proc Natl Acad Sci USA, 82, 672, 10.1073/pnas.82.3.672 Siraganian, 1970, Antigenic release of histamine from rabbit leukocytes, J Immunol, 104, 1340, 10.4049/jimmunol.104.6.1340 Siraganian, 1971, Destruction of rabbit platelets in the allergic response of sensitized leukocytes, J Immunol, 106, 1244, 10.4049/jimmunol.106.5.1244 Stahl, 1989, Protective effects of a specific platelet-activating factor (PAF) antagonist, WEB 2086, in traumatic shock, Thromb Res, 53, 327, 10.1016/0049-3848(89)90107-2 Stahl, 1988, Salutary consequences of blockade of platelet activating factor in hemorrhagic shock, Eur J Pharmacol, 149, 233, 10.1016/0014-2999(88)90653-X Stahl, 1988, Detection of platelet-activating factor during traumatic shock, Circ Shock, 26, 237 Stahl, 1987, Heterogeneity of vascular smooth muscle responsiveness to lipid vasoactive mediators, Blood Vessels, 24, 24 Stahl, 1987, Mechanisms of platelet-activating factor-induced cardiac depression in the isolated perfused rat heart, Circ Shock, 23, 165 Stahl, 1987, PAF-acether induced cardiac dysfunction in the isolated perfused guinea pig heart, Naunyn-Schmiedeberg's Arch Pharmacol, 336, 459, 10.1007/BF00164883 Stahl, 1988, Role of platelet-activating factor (PAF) in the propagation of myocardial ischemic damage in the rat, J Pharmacol Exptl Therap, 24, 898 Stewart AG, Piper PJ: Platelet-activating antagonists inhibit antigen-induced coronary vasoconstriction in guinea-pig hearts. Sixth Conference on Prostaglandins and Related Compounds, Florence, Italy, 1986, p 311 (Abstr) Sun, 1988, Bowel necrosis induced by tumor necrosis factors in rats is mediated by platelet-activating factor, J Clin Invest, 81, 1328, 10.1172/JCI113459 Sybertz EJ,Watkins RW, Vemulapalli S:AGEPC, a vasodilator phospholipid with profound circulatory actions. In Recent Advances in Arterial Diseases: Atherosclerosis, Hypertension and Vasospasm. Alan R. Liss, Inc, pp 133-156, 1986 Sybertz, 1984, Cardiac, coronary and peripheral vascular effects of acetyl glyceryl ether phosphorylcholine in the anesthetized dog, J Pharmacol Exptl Therap, 232, 156 Tamargo, 1985, Electrophysiological effects of platelet-activating factor (PAF-acether) in guinea-pig papillary muscles, Eur J Pharmacol, 109, 219, 10.1016/0014-2999(85)90423-6 Tanaka, 1983, Studies on the hypotensive effects of platelet activating factor (PAF, l-0-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine) in rats, guinea pigs, rabbits, and dogs, J Pharmacol Dyn, 6, 866, 10.1248/bpb1978.6.866 Tanniere, 1987, Direct effects of platelet activating factor (PAF) on cardiac function in isolated guinea pig heart, Drug Dev Res, 11, 177, 10.1002/ddr.430110305 Terashita, 1985, Is platelet activating factor (PAF) a mediator of endotoxin shock?, Eur J Pharmacol, 109, 257, 10.1016/0014-2999(85)90427-3 Terashita, 1987, A lethal role of platelet activating factor in anaphylactic shock in mice, J Pharmacol Exptl Therap, 243, 378 Terashita, 1987, CV-6209, a highly potent antagonist of platelet activating factor in vitro and in vivo, J Pharmacol Exptl Therap, 242, 263 Terashita, 1988, Protective action of prostaglandin E1 (PGE1) against constrictor mediators in isolated rat heart and lung, Biochem Pharmacol, 37, 2659, 10.1016/0006-2952(88)90260-2 Terashita, 1983, CV-3988—A specific antagonist of platelet-activating factor (PAF), Life Sci, 32, 1975, 10.1016/0024-3205(83)90049-8 Toth, 1986, Effects of a platelet-activating factor antagonist, CV-3988, on different shock models in the rat, Circ Shock, 20, 193 Touqui, 1985, l-0-alkyl-2-acyl-sn-glycero-3-phosphorylcho-line is the precursor of platelet-activating factor in stimulated rabbit platelets. Evidence for an alkylacetylglycero-phosphorylcholine cycle, Biochim Biophys Acta, 833, 111, 10.1016/0005-2760(85)90258-9 Touqui, 1987, The role of calcium in regulating the catabolism of PAF-acether (l-0-alkyl-2-acyl-sn-glycero-3-phosphorylcholine) by rabbit platelet, Biochem J, 241, 555, 10.1042/bj2410555 Vargafig, 1984, Platelet aggregation and PAF-acether, pharmacological interferences, J Pharmacol (Paris), 15, 69 Wallace, 1986, Effects of inhibitors of arachidonic acid metabolism on PAF-induced gastric mucosal necrosis and haemoconcentration, Br J Pharmacol, 89, 415, 10.1111/j.1476-5381.1986.tb10275.x Wang, 1987, Platelet-activating factor mediates endotoxin-induced acute renal insufficiency in rats, Am J Physiol, 253, F1283 Whittle, 1987, Increased intestinal formation of PAF in endotoxin-induced damage in the rat, Br J Pharmacol, 92, 3, 10.1111/j.1476-5381.1987.tb11287.x Wu, 1986, Inhibition of the platelet activating factor (PAF)-induced in vivo responses in rats by trans-2,5-93,4,5-trimethoxyphenyl) tetrahydrofuran (L-652,731), a PAF receptor antagonist, J Pharmacol Exptl Therap, 239, 841 Wykle, 1980, Enzymatic synthesis of l-0-alkyl-2-acyl-sn-glycero-3-phosphorylcholine, a hypotensive and platelet-aggregating lipid, J Biol Chem, 255, 10256, 10.1016/S0021-9258(19)70457-8 Wykle RL, Olson SC, O'Flaherty JT: Biochemical pathways of platelet activating factor synthesis and breakdown. In Otterness I, et al (eds): Adv Inflammation Res, Vol II, 1986, p 7181